Company needs to put 100% their focus on the American market. Australia doesn't have the population or the government support for Promarker D so, I doubt people are going to jump over themselves to pay for this test here.
Also, I am not sure why the Endo and Eso tests are priced so high here and, in the US, as it seems like that could be an inhibitor to strong sales if no government support is available for the patient?
Ann: Chinese patent granted for OxiDx technology, page-23
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $62.19M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.0¢ | $53.71K | 143.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 491 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 39195 | 2 |
View Market Depth
| Last trade - 15.55pm 07/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |